Colinz Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Colinz Laboratories	Parmax Pharma	Cian Healthcare
Operational Metrics
Financials
5 yr Average ROE	4.71 %	-1068.03 %	-17.04 %
5yr average Equity Multiplier	1.29	29.23	3.21
5yr Average Asset Turnover Ratio	0.64	1.05	0.39
5yr Avg Net Profit Margin	5.84 %	-11.29 %	-17.41 %
Price to Book	1.21	0.0	0.4
P/E	25.9	0.0	0.0
5yr Avg Cash Conversion Cycle	-11.59 Days	-92.25 Days	55.28 Days
Inventory Days	56.66 Days	69.37 Days	219.95 Days
Days Receivable	42.5 Days	20.01 Days	224.43 Days
Days Payable	89.1 Days	296.94 Days	542.88 Days
5yr Average Interest Coverage Ratio	11.55	-0.77	-0.81
5yr Avg ROCE	6.71 %	-14.3 %	-0.26 %
5yr Avg Operating Profit Margin	7.54 %	2.43 %	7.22 %
5 yr average Debt to Equity	0.07	10.96	1.21
5yr CAGR Net Profit	18.95 %	n/a	n/a
5yr Average Return on Assets	3.68 %	-9.05 %	-3.63 %
Shareholdings
Promoter Holding	66.0 %	30.8 %	27.1 %
Share Pledged by Promoters	0.0	0.0	34.48 %
Change in Promoter Holding (3 Yrs)	0.07 %	0.0	-43.79 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0